Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Catalyst Pharmaceuticals (CPRX) Asset Utilization Ratio (2018 - 2025)

Historic Asset Utilization Ratio for Catalyst Pharmaceuticals (CPRX) over the last 12 years, with Q3 2025 value amounting to 0.57.

  • Catalyst Pharmaceuticals' Asset Utilization Ratio fell 826.42% to 0.57 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.57, marking a year-over-year decrease of 826.42%. This contributed to the annual value of 0.74 for FY2024, which is 2097.07% down from last year.
  • As of Q3 2025, Catalyst Pharmaceuticals' Asset Utilization Ratio stood at 0.57, which was down 826.42% from 0.59 recorded in Q2 2025.
  • Over the past 5 years, Catalyst Pharmaceuticals' Asset Utilization Ratio peaked at 0.9 during Q4 2023, and registered a low of 0.57 during Q3 2025.
  • Moreover, its 5-year median value for Asset Utilization Ratio was 0.62 (2021), whereas its average is 0.66.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first tumbled by 4032.51% in 2021, then soared by 4915.88% in 2023.
  • Over the past 5 years, Catalyst Pharmaceuticals' Asset Utilization Ratio (Quarter) stood at 0.61 in 2021, then fell by 1.06% to 0.6 in 2022, then skyrocketed by 49.16% to 0.9 in 2023, then tumbled by 32.81% to 0.61 in 2024, then fell by 5.67% to 0.57 in 2025.
  • Its Asset Utilization Ratio stands at 0.57 for Q3 2025, versus 0.59 for Q2 2025 and 0.61 for Q1 2025.